pharmadog

News

when

Latest
Archive

by source

All Sources
Sources Page

Jobs

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

made by humans and a good dog

home
jobs
news
search

calendar

31,661 catalysts · 12,072 approval · 5,000 device 510k · 4,728 grant · 3,070 8k filing · 2,000 device pma · 2,000 device recall

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

sort

soonest latest type sponsor alpha

from 2014-04-07×clear all

type

approval12,072
device 510k5,000
grant4,728
8k filing3,070
device pma2,000
device recall2,000

recall

1,126

device adverse event1,000

earnings583

phase 2 completion172

therapy area

Oncology148
Infectious Disease46
Cardiology37
Immunology35
Dermatology31
Pulmonology22
Women's Health19
Ophthalmology16
Pain15

Week of Sep 7, 2015

›Sep 10, 2015approval3989d agoOXYCONTIN (OXYCODONE HYDROCHLORIDE) — FDA approvalOXYCODONE HYDROCHLORIDE

Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →OXYCODONE HYDROCHLORIDE →fda approvals ↗

›Sep 11, 2015approval3988d agoDATSCAN (IOFLUPANE I-123) — FDA approval

Sponsor: GE HLTHCARE INC. Form: SOLUTION. Route: INTRAVENOUS

full page →fda approvals ↗

›Sep 11, 2015approval3988d agoFENTANYL-75 (FENTANYL) — FDA approvalDifGen Pharmaceuticals LLC

Sponsor: DIFGEN PHARMS. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL

full page →fda approvals ↗

Week of Sep 14, 2015

›Sep 14, 2015approval3985d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Sep 14, 2015approval

Week of Sep 21, 2015

›Sep 21, 2015approval3978d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Sep 21, 2015approval

Week of Sep 28, 2015

›Sep 28, 2015approval3971d agoTRIUMEQ (ABACAVIR SULFATE) — FDA approvalViiV Healthcare Company

Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Sep 29, 2015approval

Week of Oct 5, 2015

›Oct 5, 2015approval3964d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalEpic Pharma LLC

Sponsor: PH HEALTH. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Oct 6, 2015approval

← prev

page 21 of 634

3985d ago

CLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Sep 15, 2015approval3984d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Sep 15, 2015approval3984d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Sep 15, 2015approval3984d agoAPTENSIO XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: RHODES PHARMS. Form: CAPSULE, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

›Sep 16, 2015approval3983d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

›Sep 16, 2015approval3983d agoAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalinsulin human

Sponsor: MANNKIND. Form: POWDER. Route: INHALATION

full page →insulin human →fda approvals ↗

›Sep 16, 2015approval3983d agoSOJOURN (SEVOFLURANE) — FDA approvalSEVOFLURANE

Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION

full page →SEVOFLURANE →fda approvals ↗

›Sep 16, 2015approval3983d agoSOJOURN (SEVOFLURANE) — FDA approvalSEVOFLURANE

Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION

full page →SEVOFLURANE →fda approvals ↗

›Sep 16, 2015approval3983d agoSOJOURN (SEVOFLURANE) — FDA approvalSEVOFLURANE

Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION

full page →SEVOFLURANE →fda approvals ↗

›Sep 17, 2015approval3982d agoZYPREXA RELPREVV (OLANZAPINE PAMOATE) — FDA approvalCHEPLAPHARM Arzneimittel GmbH

Sponsor: CHEPLAPHARM. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

full page →fda approvals ↗

›Sep 17, 2015approval3982d agoVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalCARIPRAZINE HYDROCHLORIDE

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →CARIPRAZINE HYDROCHLORIDE →fda approvals ↗

›Sep 17, 2015approval3982d agoVRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalCARIPRAZINE HYDROCHLORIDE

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

full page →CARIPRAZINE HYDROCHLORIDE →fda approvals ↗

›Sep 18, 2015approval3981d agoSABRIL (VIGABATRIN) — FDA approvalVIGABATRIN

Sponsor: LUNDBECK PHARMS LLC. Form: TABLET. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

›Sep 18, 2015approval3981d agoSABRIL (VIGABATRIN) — FDA approvalVIGABATRIN

Sponsor: LUNDBECK PHARMS LLC. Form: FOR SOLUTION. Route: ORAL

full page →VIGABATRIN →fda approvals ↗

3978d ago

DOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Sep 21, 2015approval3978d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Sep 21, 2015approval3978d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Sep 21, 2015approval3978d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Sep 22, 2015approval3977d agoBOSULIF (BOSUTINIB MONOHYDRATE) — FDA approvalAlembic Pharmaceuticals Inc

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Sep 22, 2015approval3977d agoSUBOXONE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalBUPRENORPHINE HYDROCHLORIDE

Sponsor: INDIVIOR. Form: FILM. Route: BUCCAL, SUBLINGUAL

full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗

›Sep 22, 2015approval3977d agoSUBOXONE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalBUPRENORPHINE HYDROCHLORIDE

Sponsor: INDIVIOR. Form: FILM. Route: BUCCAL, SUBLINGUAL

full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗

›Sep 22, 2015approval3977d agoFLONASE ALLERGY RELIEF (FLUTICASONE PROPIONATE) — FDA approvalParatek Pharmaceuticals Inc

Sponsor: HALEON US HOLDINGS. Form: SPRAY, METERED. Route: NASAL

full page →fda approvals ↗

›Sep 23, 2015approval3976d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

›Sep 23, 2015approval3976d agoDEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

›Sep 23, 2015approval3976d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗

›Sep 23, 2015approval3976d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →ALENDRONATE SODIUM →fda approvals ↗

›Sep 23, 2015approval3976d agoGAZYVA (OBINUTUZUMAB) — FDA approvalobinutuzumab

Sponsor: GENENTECH. Form: INJECTABLE. Route: INJECTION

full page →obinutuzumab →fda approvals ↗

›Sep 25, 2015approval3974d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

full page →tramadol hydrochloride ER →fda approvals ↗

3970d ago

ESTRING (ESTRADIOL) — FDA approvalestradiol ER

Sponsor: PFIZER. Form: INSERT, EXTENDED RELEASE. Route: VAGINAL

full page →estradiol ER →fda approvals ↗

›Sep 29, 2015approval3970d agoESTRING (ESTRADIOL) — FDA approvalestradiol ER

Sponsor: PFIZER. Form: INSERT, EXTENDED RELEASE. Route: VAGINAL

full page →estradiol ER →fda approvals ↗

›Sep 29, 2015approval3970d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalBayer HealthCare Pharmaceuticals Inc

Sponsor: UNIQUE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Sep 29, 2015approval3970d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalBayer HealthCare Pharmaceuticals Inc

Sponsor: UNIQUE. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Sep 30, 2015approval3969d agoOPDIVO (NIVOLUMAB) — FDA approvalnivolumab

Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION

full page →nivolumab →fda approvals ↗

›Sep 30, 2015approval3969d agoFLONASE ALLERGY RELIEF (FLUTICASONE PROPIONATE) — FDA approvalParatek Pharmaceuticals Inc

Sponsor: HALEON US HOLDINGS. Form: SPRAY, METERED. Route: NASAL

full page →fda approvals ↗

›Oct 1, 2015approval3968d agoLEVOCETIRIZINE DIHYDROCHLORIDE — FDA approvalLEVOCETIRIZINE DIHYDROCHLORIDE

Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL

full page →LEVOCETIRIZINE DIHYDROCHLORIDE →fda approvals ↗

›Oct 1, 2015approval3968d agoLEVOCETIRIZINE DIHYDROCHLORIDE — FDA approvalLEVOCETIRIZINE DIHYDROCHLORIDE

Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL

full page →LEVOCETIRIZINE DIHYDROCHLORIDE →fda approvals ↗

›Oct 1, 2015approval3968d agoXTANDI (ENZALUTAMIDE) — FDA approvalenzalutamide

Sponsor: ASTELLAS. Form: CAPSULE. Route: ORAL

full page →enzalutamide →fda approvals ↗

›Oct 2, 2015approval3967d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →pembrolizumab →fda approvals ↗

3963d ago

CIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗

›Oct 6, 2015approval3963d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗

›Oct 6, 2015approval3963d agoTAMSULOSIN HYDROCHLORIDE — FDA approvalSynthon Pharmaceuticals Inc (Inactive)

Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Oct 6, 2015approval3963d agoTAMSULOSIN HYDROCHLORIDE — FDA approvalSynthon Pharmaceuticals Inc (Inactive)

Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Oct 6, 2015approval3963d agoTAMSULOSIN HYDROCHLORIDE — FDA approvalSynthon Pharmaceuticals Inc (Inactive)

Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

$PYPD4.7700-1.45%

$ABBV247.97+0.78%

$PYPD4.7700-1.45%

$ABBV247.97+0.78%

$MNKD3.9300-4.38%

$COLL27.20-7.70%

$INDV38.47-0.90%

$ABBV247.97+0.78%

$PFE27.05+1.08%

$ABBV247.97+0.78%

$PFE27.05+1.08%

$BMY64.84+0.19%